Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects-Reference-Cited by-同舟云学术

Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects

Published:2014-01-17 Issue:6 Volume:54 Page:657-664
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Urata Y.¹,Paintsil E.²,Cheng Y.-C.³,Matsuda T.¹,Sevinsky H.⁴,Hawthorne D.⁴,Bertz R.⁴,Hanna G.J.⁴,Grasela D.⁴,Hwang C.⁴

Affiliation:

1. Oncolys BioPharma; Tokyo Japan

2. Department of Pediatrics and Department of Pharmacology; Yale University School of Medicine; New Haven CT USA

3. Department of Pharmacology; Yale University School of Medicine; New Haven CT USA

4. Bristol-Myers Squibb; Research and Development; Princeton NJ USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.252/fullpdf

Reference30 articles.

1. European AIDS Clinical Society http://www.europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/EACSGuidelines-v6.1-English.pdf

2. Panel on Antiretroviral Guidelines for Adults and Adolescents http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf

3. World Health Organization http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf

4. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort;Cherry;Neurology.,2006

5. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea;Moore;AIDS.,2000

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4′-Modified Nucleosides for Antiviral Drug Discovery: Achievements and Perspectives;Accounts of Chemical Research;2022-01-25